Touchstone International Medical Science Co Ltd

688013 · SHG · Healthcare / Medical Instruments & Supplies

21.72CNY-0.86 (-3.81%)

Price History

Full chart

Market Stats

Previous Close22.58

Open22.62

Day Range21.30 – 22.75

52-Week Range21.11 – 60.41

Volume2.09M

Market Cap2.01B

P/E (TTM)39.38

Forward P/E0.00

EPS0.63

Dividend Yield5.24%

Beta0.23

50-Day Avg24.57

200-Day Avg33.57

About

Touchstone International Medical Science Co., Ltd. researches and develops, manufactures, and sells medical devices in China, the United States, Europe, Japan, Russia, Brazil, South Korea, Canada, Australia, and internationally. It provides laparoscopic, tube-type, intraluminal, endoscopic linear cutters and reloads, linear cutters and reloads, auto purse string clamps, and linear staplers and reloads, as well as proctological, circumcision, and circular staplers. It offers its products for use in laparoscopic and open surgeries. The company was founded in 2003 and is based in Suzhou, the People's Republic of China.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOMr. Shui Cheng Ding
Employees289
HeadquartersNo. 278, Dongping Street, Suzhou, China, 215123, China
Websitehttps://www.touchstone.hk

Leadership

Mr. Shui Cheng DingR&D Technical Director · b. 1968

Financials

Income Statement

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	89.65M	119.03M	172.76M	163.34M	213.74M	232.03M	253.65M	272.37M	326.74M
Growth (%)	-	+32.77%	+45.14%	-5.45%	+30.85%	+8.56%	+9.31%	+7.38%	+19.96%
Cost of Revenue	35.12M	49.23M	69.03M	68.25M	91.27M	99.80M	111.80M	113.64M	117.87M
Gross Profit	54.53M	69.80M	103.73M	95.09M	122.47M	132.23M	141.85M	158.73M	326.74M
Gross Margin	60.83%	58.64%	60.04%	58.22%	57.30%	56.99%	55.92%	58.28%	100.00%
Operating Expense	40.88M	46.00M	58.58M	60.74M	77.59M	88.12M	95.42M	103.73M	232.50M
Operating Income	13.65M	23.80M	45.15M	34.35M	44.88M	44.12M	46.43M	55.00M	94.24M
Operating Margin	15.23%	20.00%	26.13%	21.03%	21.00%	19.01%	18.31%	20.19%	28.84%
EBITDA	18.17M	31.30M	54.54M	46.84M	53.39M	54.33M	57.19M	64.39M	102.98M
EBITDA Margin	20.27%	26.30%	31.57%	28.68%	24.98%	23.41%	22.55%	23.64%	31.52%
Net Income	13.91M	23.13M	42.01M	34.95M	41.42M	43.20M	47.31M	51.89M	84.09M
Net Income Margin	15.51%	19.43%	24.32%	21.40%	19.38%	18.62%	18.65%	19.05%	25.74%
R&D	8.23M	10.63M	14.10M	15.37M	29.28M	34.75M	35.32M	35.99M	51.30M
R&D as % of Total Revenue	9.18%	8.93%	8.16%	9.41%	13.70%	14.98%	13.92%	13.21%	15.70%
Interest Expense	87.75K	509.10K	492.90K	98.53K	72.97K	274.23K	194.76K	375.59K	473.45K
Interest Expense % of Total Revenue	0.10%	0.43%	0.29%	0.06%	0.03%	0.12%	0.08%	0.14%	0.14%

Balance Sheet

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	98.57M	116.95M	124.91M	485.24M	544.83M	543.46M	626.61M	637.24M	672.93M
Total Liabilities	18.72M	34.05M	17.72M	19.35M	32.71M	35.04M	55.08M	55.81M	107.37M
Total Equity	79.84M	82.90M	107.18M	465.89M	512.13M	508.41M	571.52M	581.43M	565.55M
Cash	22.89M	18.52M	18.84M	126.78M	75.42M	33.05M	211.53M	64.13M	122.84M
Total Debt	-	9.00M	-	-	-	961.66K	1.96M	1.08M	-
Net Debt	-22.89M	-9.52M	-18.84M	-126.78M	-75.42M	-32.09M	-209.58M	-63.05M	-

Cash Flow

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	7.88M	34.44M	34.82M	42.08M	60.98M	50.40M	82.95M	53.41M	71.99M
Investing Cash Flow	-15.03M	-23.68M	-5.89M	-257.10M	-100.59M	-29.23M	97.97M	-147.20M	-
Financing Cash Flow	0	-9.01M	-29.75M	321.19M	-16.00M	-67.39M	-4.74M	-53.66M	-
Capital Expenditure	15.21M	20.78M	9.41M	7.29M	9.21M	47.67M	18.41M	41.94M	90.75M
Free Cash Flow	-7.32M	13.66M	25.41M	34.79M	51.77M	2.73M	64.54M	11.47M	-18.76M
Dividends Paid	-	18.01M	18.00M	16.00M	16.00M	15.81M	19.80M	38.31M	121.58M
FCF to OCF	-92.91%	39.66%	72.97%	82.67%	84.90%	5.42%	77.80%	21.47%	-26.07%
Dividend Paid to FCF	-	131.86%	70.84%	45.99%	30.91%	578.90%	30.68%	334.00%	-647.94%

Earnings

Report Date	Oct 26, 2020	Feb 24, 2021	Apr 30, 2021	Aug 22, 2021	Oct 27, 2021	Dec 31, 2021	Apr 28, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Apr 28, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.16	0.11	0.16	0.15	0.14	0.06	0.06	0.15	0.15	0.15	0.14
Surprise	-	-	-	-	-	-	-	-	-	-	-
Timing	After-hours	Pre-market	Pre-market	After-hours	Pre-market	-	Pre-market	-	-	-	Pre-market

Key Statistics & Ratios

Market Cap2.01B

Enterprise Value1.94B

Trailing P/E39.38

Forward P/E0.00

Price / Sales7.09

Price / Book4.16

EPS0.63

Book Value6.18

Revenue (TTM)283.90M

Gross Profit (TTM)180.60M

EBITDA54.15M

Profit Margin17.86%

Operating Margin4.52%

Return on Equity9.49%

Return on Assets4.06%

Shares Outstanding81.16M

Shares Float34.86M

Beta0.23

Dividend Yield5.24%

Dividend Rate1.30

Payout Ratio206.35%

Dividends

20261×

0.80Jun 26, 2026

20253×

0.50Oct 16, 20250.50Jun 11, 20250.50Jan 24, 2025

20241×

0.50Oct 11, 2024

20231×

0.25Jun 27, 2023

20221×

0.20Jun 23, 2022

20211×

0.20Jun 18, 2021